These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18470535)

  • 1. Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials.
    Shi GM; Xu Y; Fan J; Zhou J; Yang XR; Qiu SJ; Liao Y; Wu WZ; Ji Y; Ke AW; Ding ZB; He YZ; Wu B; Yang GH; Qin WZ; Zhang W; Zhu J; Min ZH; Wu ZQ
    J Cancer Res Clin Oncol; 2008 Nov; 134(11):1155-63. PubMed ID: 18470535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study.
    Sukowati CH; Anfuso B; Torre G; Francalanci P; Crocè LS; Tiribelli C
    PLoS One; 2013; 8(10):e76830. PubMed ID: 24116172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between DLC-1 expressions and metastasis in hepatocellular carcinoma].
    Song LJ; Ye SL; Wang KF; Weng YQ; Liang CM; Sun RX; Zhao Y; Liu YK; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):428-31. PubMed ID: 15975276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell-like side populations in esophageal cancer: a source of chemotherapy resistance and metastases.
    Zhao Y; Bao Q; Schwarz B; Zhao L; Mysliwietz J; Ellwart J; Renner A; Hirner H; Niess H; Camaj P; Angele M; Gros S; Izbicki J; Jauch KW; Nelson PJ; Bruns CJ
    Stem Cells Dev; 2014 Jan; 23(2):180-92. PubMed ID: 24021093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of CD9 expression reduces the metastatic capacity of human hepatocellular carcinoma cell line MHCC97-H.
    Lin Q; Peng S; Yang Y
    Int J Oncol; 2018 Jul; 53(1):266-274. PubMed ID: 29749468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin enhances the sensitivity of hepatocellular carcinoma side population cells to doxorubicin via miR-491/ABCG2.
    Xie ZY; Liu MS; Zhang C; Cai PC; Xiao ZH; Wang FF
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30120100
    [No Abstract]   [Full Text] [Related]  

  • 7. Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics.
    Li Y; Tian B; Yang J; Zhao L; Wu X; Ye SL; Liu YK; Tang ZY
    J Cancer Res Clin Oncol; 2004 Aug; 130(8):460-8. PubMed ID: 15146329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties.
    Chiba T; Kita K; Zheng YW; Yokosuka O; Saisho H; Iwama A; Nakauchi H; Taniguchi H
    Hepatology; 2006 Jul; 44(1):240-51. PubMed ID: 16799977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of green fluorescent protein-expressing hepatocellular carcinoma cell lines with different metastatic potential: relevant models for in vivo monitoring of metastasis and angiogenesis.
    Xu Y; Sun HC; Tian B; Li Y; Chen J; Chen J; Gao DM; Xue Q; Tang ZY
    J Cancer Res Clin Oncol; 2004 Jul; 130(7):375-82. PubMed ID: 15133661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isocorydine targets the drug-resistant cellular side population through PDCD4-related apoptosis in hepatocellular carcinoma.
    Lu P; Sun H; Zhang L; Hou H; Zhang L; Zhao F; Ge C; Yao M; Wang T; Li J
    Mol Med; 2012 Sep; 18(1):1136-46. PubMed ID: 22714713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of ezrin on the proliferation and the invasiveness of cells of different hepatocellular carcinoma cell lines].
    Zhang Y; Hu MY; Chen BH; Wang ZJ; Wu WZ; Zhou K; Liu KD
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):489-94. PubMed ID: 16867268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of lung tissue extracts to invasion and migration of human hepatocellular carcinoma cells with various metastatic potentials.
    Ji XN; Ye SL; Li Y; Tian B; Chen J; Gao DM; Chen J; Bao WH; Liu YK; Tang ZY
    J Cancer Res Clin Oncol; 2003 Oct; 129(10):556-64. PubMed ID: 12942314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BTG2 Is Down-Regulated and Inhibits Cancer Stem Cell-Like Features of Side Population Cells in Hepatocellular Carcinoma.
    Huang CS; Zhai JM; Zhu XX; Cai JP; Chen W; Li JH; Yin XY
    Dig Dis Sci; 2017 Dec; 62(12):3501-3510. PubMed ID: 29098552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tex10 is upregulated and promotes cancer stem cell properties and chemoresistance in hepatocellular carcinoma.
    Xiang X; Deng L; Xiong R; Xiao D; Chen Z; Yang F; Liu K; Feng G
    Cell Cycle; 2018; 17(11):1310-1318. PubMed ID: 30045663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
    BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The expression and significance of vascular endothelial growth factor and its receptors in hepatocellular carcinoma cell lines with various metastatic potentialities].
    Ai JH; Zheng SG; Zeng YY; Xiong Y; Zhang LD; Dong JH
    Zhonghua Gan Zang Bing Za Zhi; 2008 Feb; 16(2):105-8. PubMed ID: 18304425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side population in hepatocellular carcinoma HCCLM3 cells is enriched with stem-like cancer cells.
    Guo Z; Jiang JH; Zhang J; Yang HJ; Zhong YP; Su J; Yang RR; Li LQ; Xiang BD
    Oncol Lett; 2016 May; 11(5):3145-3151. PubMed ID: 27123080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling.
    Hu C; Li H; Li J; Zhu Z; Yin S; Hao X; Yao M; Zheng S; Gu J
    Carcinogenesis; 2008 Dec; 29(12):2289-97. PubMed ID: 18820285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma.
    Li M; Zhang L; Ge C; Chen L; Fang T; Li H; Tian H; Liu J; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li J
    Oncotarget; 2015 Sep; 6(28):25149-60. PubMed ID: 26327240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.